- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Park looks for strategic partner
Nuclear medicine vendor Park Meditech announced that it will actively seek a strategic partner to assist the company in maximizing its technology within the nuclear medicine market.The announcement came with the release of financial results for the first
Nuclear medicine vendor Park Meditech announced that it will actively seek a strategic partner to assist the company in maximizing its technology within the nuclear medicine market.
The announcement came with the release of financial results for the first six months of 1997 (end-January), which saw the vendor report increased revenues but also a slight increase in its net loss.
For the six-month period, revenues were $4.6 million (Canadian), compared with $3.2 million (Canadian) for the same period in 1996. The company posted a net loss of $5 million (Canadian), compared with $4.9 million in 1996.
The company also reported that the operational reorganization begun in February has mostly been completed (SCAN 3/5/97). In addition, the vendor is shipping its scheduled backlog and is continuing to move ahead in the development of new products, according to Richard Mullen, president and CEO.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
